Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Alpha Wealth Funds - The Insiders Fund. This analysis is provided for institutional research purposes only and is not investment advice.
"The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the period 95% invested in a supportive 'goldilocks' environment."
The Insiders Fund, LP ended June 2025 up ~5.27%, with YTD returns reaching ~8-9%. Outperforming the S&P 500's downside volatility, the fund has rotated significantly into tech (Alphabet, AMD, Applied Materials) and reduced healthcare sector exposure due to anticipated policy headwinds from DOGE and HHS. Major positions in Energy Transfer and AppFolio highlight the fund's strategy of navigating tariff risks. The fund remains 95% invested, pointing to lower interest rates and priced-in geopolitical risks as supportive factors for a continuation of the market's bullish trend.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
High-conviction positioning: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Growth Outlook
Market outlook remains high conviction: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Risk Appetite
Risk appetite posture is high conviction: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Capital Deployment
Manager actively deployed capital into high-conviction opportunities. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Forward Guidance
Forward guidance signal: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Language Signal
Tone analysis indicates above average conviction language: The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Perceived Risk
Perceived risk level is evaluated as moderate conviction. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Opportunity Density
Opportunity density index indicates above average conviction actionable entry points. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
Time Horizon
Investment time horizon reflects a above average conviction orientation. The Insiders Fund delivered ~8-9% YTD return through Q2 2025. The manager has concentrated capital into tech giants like Alphabet and AMD while cutting biotech exposure, ending the...
